mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.28 |
0.4 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.4 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |